# Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

> **NCT01868594** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 200 (actual)

## Conditions studied

- Type I Diabetes Mellitus

## Interventions

- **DRUG:** Subetta
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01868594
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01868594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01868594, "Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01868594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*